Location History:
- Dallas, TX (US) (2019 - 2022)
- Coppell, TX (US) (2022 - 2024)
Company Filing History:
Years Active: 2019-2025
Title: Heping Shi: Innovator in Immunotherapy
Introduction
Heping Shi is a prominent inventor based in Dallas, TX, known for his significant contributions to the field of immunotherapy. With a total of 17 patents to his name, he has made remarkable advancements in medical therapies that leverage antibody-drug conjugates.
Latest Patents
Among his latest patents are "Antibody-sting agonist conjugates and their use in immunotherapy," which focuses on antibody-drug conjugates that incorporate a STING agonist cyclic di-nucleotide. This innovation outlines preparation methods and various applications in immunotherapy. Another notable patent is for "Quinoline cGAS antagonist compounds," which details compounds that act as cGAS antagonists, including their preparation methods and pharmaceutical compositions for medical therapy.
Career Highlights
Heping Shi has worked with esteemed organizations such as the University of Texas System and Immunesensor Therapeutics, Inc. His work in these institutions has been pivotal in advancing research and development in immunotherapy.
Collaborations
Heping has collaborated with notable colleagues, including Lijun Sun and Chuo Chen, contributing to a dynamic research environment that fosters innovation.
Conclusion
Heping Shi's work exemplifies the intersection of innovation and medical science, making significant strides in immunotherapy through his patents and collaborations. His contributions continue to influence the field and pave the way for future advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.